等待開盤 09-30 09:30:00 美东时间
+0.180
+12.00%
经济观察网9月19日至20日,辉瑞中国“潮起钱塘·智启未来”第二届智慧医疗创新生态大会在杭州举办。此次大会,辉瑞现场带来V-Track院内药品科学管...
09-24 17:43
An update from Coherus Biosciences ( ($CHRS) ) is now available. On June 30, 20...
09-08 22:18
(来源:动脉网) 当前,全球医药产业的核心竞争力已由单一的药物研发创新迈向“超越药片”的创新解决方案的新阶段,MNC正在重新定义自身的战略边界与发展路径。 医...
09-08 11:25
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-04 22:05
Maxim Group analyst Jason McCarthy upgrades Coherus Oncology (NASDAQ:CHRS) from Hold to Buy and announces $4 price target.
09-04 20:09
Coherus Oncology announced its participation in three upcoming conferences: the Baird Global Healthcare Conference on September 9, 2025; the H.C. Wainwright Global Investment Conference on September 10, 2025; and UBS Virtual Oncology Day on October 1, 2025. Presentations will be available via webcast on the company's Investor Events page, with replays accessible for 30 days. Coherus, focused on advancing its oncology portfolio, including its PD-1...
09-03 12:30
Coherus BioSciences (NASDAQ:CHRS) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.28) by 22.74 percent. This is a 142.86 percent decrease over losses of $(0.14) per share
08-08 05:16
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Coherus Oncology announced its second-quarter 2025 financial results will be released after market close on August 7, 2025. A conference call and webcast to discuss the results and provide a business update will begin at 5:00 p.m. EDT on the same day. Conference call dial-in details and webcast links are provided, with a replay available on the company's investor website. Coherus is an oncology company with an approved PD-1 inhibitor, LOQTORZI, g...
07-31 20:45